A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.


Updates from The Motley Fool

Latest updates on SciClone Pharmaceuticals from Fool.com.
SciClone Hires a CFO

The company taps veteran finance executive Wilson Cheung for the the job.

The Fool Looks Ahead

Software and soft wears will have starring roles in the week that lies ahead.

3 Stocks Ready to Roar

Some investors are getting behind these stocks that might be on the brink of moving up.



Stock Performance

View Interactive SCLN Charts
Sponsored by

Key Data Points

Primary metrics and data points about SciClone Pharmaceuticals.
Current Price: $9.50
Prev Close: $9.40
Open: $9.45
Bid: $9.00
Ask: $9.90
Day's Range: $9.22 - $9.55
52wk Range: $8.55 - $15.02
Volume: 374,962
Avg Vol 224,430
Market Cap: $489M
P/E (ttm): 16.21
EPS (ttm): $0.58
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about SciClone Pharmaceuticals.
CAPS Rating 5 out of 5
 
164 Outperform
12 Underperform
CAPS All Stars
 
21 Outperform
2 Underperform

How do you think SciClone Pharmaceuticals will perform against the market?



You pick for SciClone Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Friedhelm Blobel, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for SciClone Pharmaceuticals.

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers